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DEFINITIONS
Intracellular calcium concentration ([Ca2+]i) transient The transient increase and decay of 
[Ca2+]i during a contraction-relaxation cycle of the cardiomyocyte; denotes the cytosolic Ca2+
changes that induce contraction and relaxation.
Ca2+-induced Ca2+ release The subcellular events that initiate cardiomyocyte contraction.
The inward L-type Ca2+ current stimulates the Ryanodine receptor to release Ca2+ from the 
sarcoplasmatic reticulum. The released Ca2+ induces myofilament contraction.
Detraining Complete withdrawal of exercise after a history of regular exercise training. 
Endothelial function Includes several faculties of arterial endothelium; is in this thesis
indicated by acetylcholine-induced nitric oxide generation in the endothelium that relaxes the 
vessel wall smooth muscle and induces vasodilation.
Fractional shortening The decrease in cardiomyocyte length from end-diastole to end-
systole divided by end-diastolic length; defines the degree of cell shortening.
Maximal oxygen uptake (VO2max) The highest oxygen uptake achievable during dynamic
exercise with large muscle groups; the best single physiological measure of aerobic fitness. 
Myofilament Ca2+ sensitivity The myofilament contractile response to any given [Ca2+]i in 
the cardiomyocyte.
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SUMMARY
Beneficial effects of exercise are closely associated with fitness and maximal oxygen uptake
(VO2max). Capacity for oxygen transport increases mainly by improved cardiac function,
including larger chamber volumes, myocardial hypertrophy, and enhanced diastolic and
systolic function. Higher arterial conductance, capillarity, and oxygen utilization in skeletal
muscle also contribute. The present thesis investigates the cellular basis for cardiac and
arterial effects; how they correlate with changes in VO2max during exercise training at high or 
moderate intensity, and during detraining.
The studies show that: 
1. Regular aerobic exercise training increases running performance and VO2max,
induces cardiac hypertrophy, and improves cardiomyocyte contractility and arterial
endothelial function.
2. High intensity exercise is more effective than moderate intensity exercise to increase
aerobic fitness.
3. VO2max correlates closely with cardiomyocytes size, contractility, and calcium handling
during adaptation in the first weeks of exercise, during detraining, and with different 
training intensities.
We conclude that: 
1. Aerobic fitness is intimately related to cardiomyocyte size and function.
2. The magnitude of adaptation to training depends on exercise intensity.
3. Intensity emerges as an important determinant for beneficial effects of exercise 
training.
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INTRODUCTION
Physical activity reduces, but does not currently prevent the Western Society epidemic of 
cardiovascular disease from either reaching global proportions or taxing public health and 
economy (6,30). Lack of physical activity and lowered level of fitness contributes to the world-
wide rise of life-style related diseases as cardiovascular disease, metabolic syndrome, and
diabetes (118). Better, affordable prevention and treatment strategies to improve wide-scale 
health are called upon. Regular physical exercise represents such a strategy (17,20). It 
improves cardiovascular function, health and quality of life, and mortality in patients and in 
those at risk of developing disease (11,18,62,65,140,143). A Cochrane meta-analysis found
that exercise training reduces mortality by 27% in coronary artery disease patients (91).
However, recommendations on physical activity in primary and secondary prevention of 
cardiovascular disease are diffuse (5,52) despite indisputable evidence of aerobic fitness as
an important clinical reference point and target (93,136). In order to develop optimal exercise 
protocols to improve health, a sound understanding of the responsible cellular biology of 
improved cardiac and vascular function after exercise training is required. Thus, this thesis
studies the relationship between aerobic fitness and cardiomyocyte and arterial function.
Aerobic Fitness is Closely Associated with Maximal Oxygen Uptake
The single most important physiological measure of aerobic fitness in both health and disease
is maximal oxygen uptake (VO2max), which refers to the maximal rate at which oxygen can be 
transported from ambient air to peripheral working skeletal muscles, where it is utilized by 
intracellular metabolic processes (160,176,177). Work economy, i.e. oxygen cost of given 
work or ratio between power output and oxygen uptake (VO2), and lactate threshold, i.e. 
highest VO2 or power output without excess congestion of lactate, also contribute to aerobic
fitness, but considerably less (77,126,145).
Determinants of Maximal Oxygen Uptake 
Analytical modeling (26,47,176,177) and laboratory approaches (154,156) assert that cardiac 
output and arterial conductive and redistributive capacity are rate-limiting to aerobic exercise
in every individual. A majority of studies indicate that VO2max is by large determined by the 
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cardiac pumping capacity, as the main drop in oxygen partial pressure occurs between the 
pulmonary and skeletal muscle capillaries (160,176,177). This implies a regulatory role for 
arterial conductance. In contrast, pulmonary work and the problem of lung perfusion/diffusion
mismatch is only rate-limiting to well-trained individuals, whereas skeletal muscle diffusion
and metabolic flux appears rate-limiting only when convective supply surpasses peripheral
demand, such as in unfit subjects or during work with only a small muscle mass (178). All 
things considered, the likelihood is that there is no sole determinant of VO2max, but rather a 
complex chain of intertwined elements working in concert (154,176,177).
Intensity of Exercise Determines Outcome
Although defining studies of healthy individuals still are lacking, clinical trials point to the 
superiority of high aerobic intensity over low-to-moderate intensity to gain full effect of a 
training program (2,89,101,157,170). The emergence of VO2max as a continuum from health to 
disease supports this notion (93,136). Cardiovascular adaptations may therefore rely on the 
exercise intensity during long-term regular training programs also in healthy individuals,
especially since it was demonstrated that stroke volume in well-trained athletes increases
continuously with increasing intensity up to maximal levels at or around peak aerobic exercise
intensity (59,194).
Exercise Training Induces Cardiomyocyte Hypertrophy
Adaptive growth of the cell in response to regular exercise (physiological hypertrophy) usually
involves proportional growth in length and width (83,128,129). This corresponds with
increased ventricular weights (8) and the phenomenon of the athletes’ heart, manifested as
increased chamber volumes and mass, and increased thickness of the left ventricle wall 
(146,147,150). Both increased gene transcription and translation seem to underlie
physiological hypertrophy (25,102). In contrast, abnormal growth in response to pressure
and/or volume overload characterizes pathologic hypertrophy, and involves early longitudinal 
cell growth followed by a later stage of proportional length and width growth (38,83).
Hypertrophy in heart failure is normally linked to reprogramming into a fetal gene program
expressing embryonic growth cascades (28). 
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Cardiomyocyte Contractile Function 
A central feature of regular exercise training is improved systolic and diastolic function and
larger cardiac output (50,59,162,186). Exercise training over months usually improves
cardiomyocyte shortening and rates of contraction-relaxation (129,187,188), providing a 
cellular basis for global function. In contrast, heart failure induces cardiac dysfunction with 
reduced ejection fraction and lower cardiac output, which also is associated with impaired 
cardiomyocyte contractile function in both man and rodent (22,38,41,66,109,110,148,165,174,
182,187). Overall, the differences that occur between species seem to be quantitative, rather 
than qualitative (14,15,167). Experimental studies of cellular effects of regular exercise
training appear therefore translatable to humans, also when exercise training is applied
therapeutically in heart failure and cardiovascular disease. Such studies suggest restored 
contractility and attenuated pathological growth as important cellular mechanisms for the 
beneficial effects of physical activity in heart failure (187,190,192).
Cardiomyocyte Contractile Machinery
Cardiomyocyte sarcomere units composed of mainly actin and myosin filaments constitute the 
contractile protein machinery, together with tropomyosin and the troponin complex. When 
Ca2+ binds to troponin C, the complex changes conformation and troponin I moves to allow
actin-myosin coupling, while troponin T attaches the complex to tropomyosin. Next, myosin 
heads bind to actin and flex to slide the filaments in opposite directions and cause shortening;
hence, the process is termed the sliding filament model. Upon release of Ca2+ from troponin
C, the machinery returns to its innate position and awaits the next contractile cycle. Titin, 
myosin binding protein C, M-protein, myomesin, nebulin and nebulette, and Į- and ȕ-actinin
serve supporting and regulatory functions (14,15).
Cardiomyocyte Excitation-Contraction Coupling and Calcium Handling 
The rapid transient increase in intracellular Ca2+ concentration ([Ca2+]i) evoke global cell 
shortening as described above. Conversely, the Ca2+ decay causes relaxation. Details of the 
subcellular events regulating Ca2+ induced Ca2+ release are illustrated in figure 1.
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Figure 1. Excitation-contraction coupling in ventricular myocytes. DHPR: L-type Ca2+ channel; NCX; Na+/Ca2+
exchanger; T-Tubule: Transverse tubule; RyR2: Ryanodine receptor-2; SR: Sarcoplasmatic reticulum; PLN: 
Phospholamban; SERCA2a: SR Ca2+ ATPase-2a. Modified from Bers (14). 
Depolarization allows a small entry of Ca2+ through the dihydropyridine receptor (DHPR; L-
type Ca2+ channel) and through reverse mode Na+/Ca2+ exchanger (NCX). The resulting
[Ca2+]i increase stimulates the ryanodine receptor-2 (RyR2) to release mM-order of Ca2+ from 
the Sarcoplasmatic Reticulum (SR). The co-location of the inward Ca2+ channels in 
transverse tubules and the RyR2 complex in SR secures a fast and efficient coupling,
whereas RyR2-embedded proteins as FKBP12.6 regulate the open probability of the RyR2 to 
prevent diastolic leakage. Localized Ca2+ release (Ca2+ sparks) coordinate and generate the
[Ca2+]i transient that induces contraction (60,104,112). Post-contraction, the main bulk of Ca2+
is re-sequestered (Ca2+ decay) by the SR Ca2+ ATPase-2a (SERCA2a), which activity is 
closely regulated by phospholamban (PLN). Thus, SERCA2a recharges the SR Ca2+ load, 
whereas normal mode NCX and plasma membrane Ca2+ ATPases translocate Ca2+ out of the 
cell to the extracellular space. This is the prevailing mechanism of cell contraction-relaxation
NCX
Ca2+
3 Na+
T-Tubule
Sarcolemma
DHPR
Ca2
Ca2
SR
SERCA2a
Ca2
Ca2
+
ATP
Ca2+
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(14,15,153), although alternatives relying on other stimuli have been suggested (48,51,80),
and rebutted (15,94,173).
Intracellular Calcium Controls Myocyte Contractility
Studies of excitation-contraction coupling and Ca2+ cycling after exercise training have 
demonstrated that increased levels of SERCA2a and PLN at least partly explain why Ca2+
handling improves and [Ca2+]i transport rates increase with regular exercise (188). Studies of
other subcellular factors that may improve cell contractility are sparse, but clues are provided 
from manipulative and mechanistic studies (27,35,76,111,119,121,151). Thus, exercise
training improve subcellular Ca2+ events that account for larger cardiomyocyte shortening and 
higher contraction-relaxation rates, although a complete cellular perspective of the underlying
biology has not yet been provided.
In contrast, abnormal excitation-contraction coupling and depressed Ca2+ handling provide
mechanisms for cardiomyocyte contractile dysfunction (60,66,68,104,109,133,148,163,182).
Reduced SERCA2a levels (54,76,84,149) and inhibited activity due to decreased
phosphorylation of PLN (16,105) reduces the SR Ca2+ cycling ability to cope with higher heart
rates, and may distort normal force-frequency relationships (38,68) and thus Frank-Starling
mechanics. The importance of SERCA2a was further documented by adenoviral gene 
therapy; restoring SERCA2a in cardiomyocytes corrected abnormal Ca2+ handling and 
contractile dysfunction (41,42), whereas targeted overexpression enhanced contractility in 
transgenics (9). Reduced SERCA2a levels may be compensated by enhanced
phosphorylation of PLN (36). However, close intrinsic control is needed to maintain balanced
Ca2+ cycling (172).
Myofilament Calcium Sensitivity
Regular exercise training increases myofilament Ca2+ responsiveness (46,188). Thus, 
increased cell shortening may not always correspond to altered bio-availability of Ca2+. The 
biological basis for altered Ca2+ sensitivity is not well defined yet, but modification in the 
contractile machinery, e.g. troponin subunits and myosin light chains have been proposed (7,
12
45,100,137). However, another plausible explanation to increased cell contractility may be 
changed cooperation of actin and myosin or other contractile proteins, independent of Ca2+.
After myocardial infarction and in heart failure, the role of myofilament Ca2+ sensitivity 
response is unsettled, as results range from decrease via no change to increase (67,69,70,
109,148,164), despite improved clinical outcome of Ca2+ sensitizers (75). It may be that 
cellular changes affecting Ca2+ sensitivity are adaptive in exercise training, and compensatory
rather than causative in heart failure, in order to increase or preserve contractile capacity.
Arterial Endothelial Function
Improved arterial endothelial function with exercise training improves conductance of blood
flow, and is associated with depressed atherosclerosis due to inhibition of leukocyte adhesion
and invasion, less platelet aggregation and adhesion, and suppressed smooth muscle
proliferation (3,23,73,97,179). Since these effects depend upon endothelial release of the 
vasoactive and anti-atherogenic agent nitric oxide (NO), it appears that measuring NO-
mediated vasorelaxation is indicative of endothelial function (99,124,138,189). In this thesis,
endothelial function is therefore indicated by acetylcholine-induced vasorelaxation (see 
below); higher artery relaxation is interpreted as improved endothelial function. Endothelial
dysfunction represents abnormalities in the pathways that regulate the level of NO. Other
vasoactive agents released from the endothelium are endothelium-derived hyperpolarizing
factor, prostacyclin, angiotensin II, thromboxane, prostaglandin, and endothelin (57,87,139).
Acetylcholine Stimulates Nitric Oxide-Mediated Vasorelaxation
The bio-availability of NO is mechanistically linked to artery relaxation and endothelial
function, as illustrated in figure 2. NO is a small uncharged radical compound produced by 
oxidation of the terminal guanidino nitrogen of the amino acid L-arginine. The process is
catalyzed by the constitutive endothelial isoform of NO synthase (eNOS), after stimulation by
acetylcholine-binding to muscarinic receptors. Next, NO enters smooth muscle cells and 
initiates the signal cascade that ultimately decreases [Ca2+]i and induces vasorelaxation
(23,138,139). Besides acetylcholine, shear stress, bradykinin, ATP, ischemia, and a large 
number of extra- and intracellular factors may also mediate NO production (23).
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Vascular
lumen
Figure 2. Acetylcholine-induced nitric oxide (NO)-dependent arterial relaxation pathway. eNOS: endothelial NO 
synthase; NO: nitric oxide; sGCi: inactivated soluble guanylate cyclase; sGCa: activated soluble guanylate cyclase;
GTP: Guanosine triphosphate; cGMP: cyclic 3`,5`-guanosine monophosphate; PKG: cGMP-dependent protein 
kinase. Modified from Walther et al (179). 
Higher level of NO in the smooth muscle cell induces relaxation and is an important cause of 
improved endothelial function after exercise training (71,179). Although endothelial function is
associated with aerobic fitness (97,189), conflicting results appear during exercise training in 
normal individuals, from increased to unchanged and decreased endothelial function (13,29, 
95,99,117,123,124). In endothelial dysfunction, acetylcholine fails to induce normal relaxation,
and may in fact induce a paradoxical vasoconstriction by binding to cholinergic receptors on 
the smooth muscle cell surface (115). Thus, endothelial (dys)function is linked to
cardiovascular health. Recent studies link improved cardiovascular health in cardiovascular
patients to corrected endothelial function due to regular exercise training (3,72,73,97,106),
partly due to enhanced phosphorylation of eNOS to restore NO-levels (71). Hence,
endothelial dysfunction reduces the levels of NO and has been identified as an independent
risk factor and marker of morbidity and mortality (74,161).
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OBJECTIVE
The main focus of the present study was to investigate the cellular basis for cardiac and
vascular contributions to aerobic fitness (VO2max).
The specific aims of the studies were to: 
1. Develop valid and reproducible procedures to determine VO2max during treadmill 
running in rats and mice.
2. Establish long-term intensity-controlled exercise training in rats and mice that yield 
robust cardiovascular effects mimicking adaptation in humans.
3. Determine how intensity of exercise influences VO2max, cardiomyocyte hypertrophy,
contractility and Ca2+ handling, and arterial endothelium-dependent relaxation. 
4. Determine the time-course of VO2max, cardiomyocyte hypertrophy, contractility and 
Ca2+ handling, and endothelial function when high-intensity exercise training is 
implemented and withdrawn.
5. Determine the relationship between cardiomyocyte contractile capacity and arterial
endothelium-dependent relaxation on one side and VO2max on the other side.
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METHODOLOGICAL CONSIDERATIONS
Animal Models 
The objective was to correlate VO2max with cardiomyocyte and endothelial function. This 
requires access to viable cells and tissues and a close control of the intensity and time course
of exercise training. Hence, procedures for exercise training and testing of VO2max were 
developed and evaluated in animal models as detailed in papers I and II, since similar studies
in humans are close to impossible. For both rodent models, availability and costs were 
favorable.
Rat
Adult female Sprague-Dawley rats were used in studies I, III, and IV, as they are previously 
well characterized in our lab (109,110,187,188) and elsewhere (43-46,190-193). Physiological
body growth is less pronounced in females; thus, data related to body mass are less
confounded than in males. As discussed below, this does not preclude gender-specificity on 
cardiac or vascular adaptations (63,142), which may affect cellular dynamics. As Sprague-
Dawley rats come from an outbred strain, the genetic variability is preferably larger than in 
inbred animals and validates the results to a wider biological background. Moreover, the 
effects of anesthesia in this strain are well-known from previous experience in our laboratory
(108-110).
Mouse
To expand future investigations to specific molecular and genetic targets via transgenic and 
gene-modified models, we extended our exercise model to adult mice. Thus, the first mouse 
training study from our laboratory is reported here (paper II). The C57BL/6J strain is inbred
and more genetically homogenous than outbred animals. Hence, it is extensively used for
pharmacological and physiological studies. Even though a recent report described it as 
inferior to other mouse strains with regard to running performance and exercise adaptability
(122), responses in study II were fairly robust.
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Exercise Training Program
To maximize cardiovascular adaptations, we chose the custom-made inclined treadmill 
running model that allows close control of exercise intensity, as our preferred model of 
exercise. The exercise sessions throughout the investigations were carried out at 85-90% of 
VO2max, interspersed by short periods of milder intensity, except in paper III, in which 
moderate intensity at 65-70% of VO2max also was employed to study cellular adaptations to 
different intensities. Uphill treadmill running is a full-body exercise that taxes the 
cardiovascular system and VO2 maximally, and reduces running speed, which otherwise
would have the potential to intrude reaching maximal work intensity (see data in papers I and 
II). Although this model may also cause stress reactions given the electrical grid (130), the 
physiological adaptations by large mimic those in humans (129,188). In comparison, other 
available exercise models as voluntary wheel running, fixed speed treadmill running or swim-
training in a water tank (8,33,79,129), give little or no control of the amount or intensity of the 
work performed. In particular, forced swimming probably involves more stress.
The light-dark cycle of the animals was adjusted to accommodate exercise sessions during
the animals’ dark cycle, as normal behavior pattern summons activity at night. Finally, animals
were rewarded chocolate after each exercise session as reinforcement to encourage treadmill
running (158). To counteract bias, sedentary animals were also given the same amounts of 
chocolate.
Testing of Oxygen Uptake
To monitor training-induced adaptations and adjust treadmill running speed to maintain the 
desired relative exercise intensity, VO2max was measured during treadmill running to 
exhaustion at the start of every training week. Running economy, i.e. VO2 at a given 
submaximal running velocity was measured after the warm-up, but before testing VO2max, to
avoid accumulation of excess lactic acid. The protocols for measuring VO2 in rats and mice
are detailed in paper I and II, respectively. The methods have been found reproducible
through several studies in our laboratory in both normal healthy and heart failure rats, and in 
rats genetically selected and bred for either high or low aerobic capacity (papers III and IV; 
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187-189). Since paper II, we have reproduced the test and training protocols for mice in later 
unpublished studies. The principles behind the VO2max test resemble those from human
subjects (181,195) and confirm that VO2max is integral for evaluating physical capacity and 
integrative function.
Anesthesia
The normal method for sacrificing animals was with diethyl ether anesthesia, which provides a 
quick comatose, but maintains a stable cardiac function that is vital for harvesting
cardiomyocytes. Intraperitoneal injections with ketamine and xylazine provided anesthesia for 
echocardiography; a mixture widely used for echocardiography recordings of both rats and
mice because of the well-defined cardiovascular effects (88,107,169). Ketamine provides
analgesia, sedation, and amnesia. It may affect hemodynamics by increasing blood pressure
and cardiac output. Hence, the lowest possible dose was used to balance depressive and 
stimulatory effects to secure adequate sedation. Following echocardiography, the animals
were observed until awakening.
Echocardiography in Rats and Mice
Global adaptations on cardiac morphology and work performance were evaluated by 
echocardiography, as described in papers II and III. 2-dimensional M-mode long-axis 
recordings providing 250 frames per second were used to evaluate left ventricular
dimensions, whereas pulsed-wave Doppler recordings at 500 Hz were used to assess flow 
characteristics, according to recommendations from the American Society of 
Echocardiography (159). From each recording, 5-10 consecutive cardiac cycles were
averaged. Although echocardiography is fairly well established as a valid tool to assess left 
ventricular dimensions and function in the rat myocardial infarction model (88,107,108,166),
its feasibility to evaluate training-induced cardiac adaptations is less certain, probably due to a 
smaller window of changes. In our hands, echocardiography was less sensitive than single
cell measurements to detect hypertrophy and different contractile function between sedentary
and trained (papers II and III; 188). This is consistent with the large number of animals 
needed to detect biologically important changes by standard equipment; ~50-60 individuals 
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would be needed to detect significant differences of 15% (Į 0.05, ȕ 0.8) of left ventricular size
between different mouse groups in standard M-mode (31). 
Cardiomyocyte Isolation
Cardiomyocytes were isolated to study cell size and function, as detailed in papers I and II. 
The procedures are modified from previous protocols for rats (82) and mice (103). Due to 
discontinued delivery of Joklik’s minimum essential medium used in I and II to isolate left 
ventricular myocytes, a slightly different solution replaced the isolation medium. Thus, studies
III and IV proceeded with Krebs Henseleit Ca2+ free solution, but with similar concentrations of 
the proteolytic collagenase type II and similar introduction to Ca2+ to ensure Ca2+ tolerability 
after isolation, which was performed in absence of Ca2+ to separate cells from each other.
Our laboratory has extensive experience with both Krebs Henseleit and Joklik’s solutions, and
no differences in cell yield and intrinsic properties were noted throughout the studies.
However, the batch of collagenase was an important source of variation in cell yield. We also
noted that different batches of laminin caused some variation in myocyte attachment to the 
cover-slips. The number of left ventricular myocyte nuclei of the rat is estimated to ~33 · 106,
whereas our average cell yield was ~3-4 · 106 from healthy left ventricles; thus, a recovery
rate of ~10%, given that most cardiomyocytes are mononucleate; some may be binucleate
(15). The percentage of rod-shaped cells was consistently ~70-75%. Only viable rod-shaped
cells without obvious cellular damage were selected for measurements of dimensions, and 
only undamaged cells that also responded to electrical stimulation were chosen for
measurements of contractility and [Ca2+]i transients. Cells that failed to complete the
stimulation protocol during the experiment were excluded from analysis. Exclusion rates were
similar in all groups. In every experiment, cells from two different groups were isolated 
simultaneously, to maintain a balanced design and avoid systematic variation. 
Electrical Stimulation of Cardiomyocytes
Electrical field stimulation is a standard and widely used means to study contractile function 
and Ca2+ dynamics in isolated cardiomyocytes, as it effectively characterizes cellular
adaptations of the heart to exercise training, heart failure, and other diseases (68,109,110,
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129,148,151,172,187-189). As a measure of contractile function, fractional shortening was
measured during continuous perfusion with HEPES solution at physiological [Ca2+] and 37˚ C. 
The magnitude of shortening was normalized to diastolic cell length, whereas changes in 
velocities of contraction and relaxation were indicated by time to half and peak shortening, or 
time from peak shortening to half-relaxation. [Ca2+]i ratio was measured simultaneously.
Fluorescence and Edge-Detection Microscopy
In order to study contractility and intracellular Ca2+ handling and homeostasis (III and IV), 
cardiomyocytes were mounted on an inverted microscope with the optical train converted to 
epifluorescence, including a xenon arc 75 W excitation source, and fluorescence emission
detection with a photometer and photomultiplier tube. Capture-and-analysis software handled
the generated data. The extent of cell shortening and the rates of cell shortening and 
relaxation were measured by a sideport camera and video edge-detection from the light/dark 
contrast of the cell edge against background. Contractility and [Ca2+]i transients were sampled
simultaneously through an Fl 40X/ 1.3 NA oil immersion objective, while cells were stimulated
by 5 ms and 1-10 Hz electrical field bipolar pulses; bipolarity to avoid electrolysis. A 500 Hz 
rotating optical chopper and bandpass filters excited the Fura-2/AM loaded cells by 
alternatively near-ultraviolet 340 nm and 380 nm wavelengths, whereas 510 nm emission was
counted to allow ratiometric evaluation of [Ca2+]i transients. When excited at 340 nm, 
fluorescence emission increases with increasing [Ca2+]i, whereas at 380 nm excitation,
emission decreases with increasing [Ca2+]i. Thus, ratioing minimizes possible aberrations of 
uneven dye loading, leakage, photobleaching and unwanted compartmentalization of Fura-2
in the cell (Grynkiewicz et al 1985). Because of uncertainty of calibration procedures and a 
non-linear relationship between the ratio and [Ca2+] (53), we used ratios without converting to 
[Ca2+]i for further analyses.
For detection of cell size, a large number of cells were video taped through either a Fl 20X/0.4 
NA or Fl 40X/0.7 NA objective, whereupon 100-150 random cells per rat and 170-250 random
cells per mouse were measured for length and midpoint width. Cells without visible damage
were selected and calibrated by a stage micrometer. The standard deviations for cell length
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and width from a pool of sedentary rat cardiomyocytes were found to be ±13 m and ±3 m,
respectively, and ±11 m and ±4 m in mice.
Cardiomyocyte Calcium Sensitivity Index
To study how the contractile properties of the cell react to a given amount of available Ca2+
(67,70,148), a Ca2+ sensitivity index was calculated as the ratio between fractional shortening
and the amplitude of the [Ca2+]i ratio from diastole to peak systole. This is not a direct
measure of the myofilament sensitivity to Ca2+; however, previous studies have established
this as an adequate index (109,188). Direct evaluation would require permeabilization of the 
plasma membrane, which would compromise contractile function, or mounting the cell to force 
transducers to trace loaded shortening in order to determine the power production of the 
given Ca2+ (46). Moreover, indirect measurements of Ca2+ sensitivity imply that the 
intracellular environment in terms of e.g. pH is not controlled, which may affect myofilament 
Ca2+ sensitivity, whereas the time lag between peak [Ca2+]i transient and peak shortening of 
the cell may to some degree distort the evaluation. Nonetheless, the Ca2+ sensitivity index 
results indicate that myofilament contractile dependence of Ca2+ in the isolated
cardiomyocytes adapts to chronic exercise.
Arterial Endothelial Function
To assess endothelial function, acetylcholine-mediated endothelium-dependent
vasorelaxation was measured by mounting the right common carotid artery onto a force 
transducer and a micrometer in a continuously equilibrated Krebs solution at 37° C, as 
detailed in papers III and IV. The protocol was adapted and modified from studies of piglet 
femoral arteries (168), and represented the first vascular assessments our laboratory
performed in rat (paper III). After the first study, it became evident that, after pre-contractions 
with the Į-agonist phenylephrine, higher concentrations of acetylcholine were required to 
ensure maximal relaxation in all artery segments (see paper III, figure 5). This was effected in 
the succeeding study (IV), whereas conventional curve-fitting methods were used to calculate
maximal relaxation levels in the artery segments that did not level off in study III. 
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Acetylcholine induces endothelium-dependent vasodilatation via muscarin receptors. To 
ascertain endothelium-dependence in the tension measurements, arterial segments from 
each animal were also exposed to L-NAME, an L-Arginine competitor that inhibits the L-
Arginine-NO pathway and thus blocks NO-production. Arterial segments were also exposed
to Na+ nitroprusside; an endothelium-independent NO-donor. The prevailing NO synthase in 
the arterial wall is eNOS (71,74), which L-NAME inhibited effectively and Na+ nitroprusside
bypassed by evoking maximal relaxation independent of endothelial NO. The interventions
confirmed that arterial vasodilatation induced by acetylcholine were endothelium-dependent.
Indomethacin was added to all experiments to exclude confounding by cyclooxygenase-
mediated prostaglandin and thromboxane-conversion from arachidonic acid.
Allometric Scaling
Since studies I and II involved both sexes and every study involved long-term follow-up, body
mass might influence the results. Thus, allometric dimensional scaling was applied to 
appropriately normalize VO2 and cardiac and skeletal muscle weights to body size. 
Traditionally, data were usually divided by blank body mass. However, this may lead to 
underestimation in heavier subjects (10,37). Measuring lean body mass is difficult and would
require body scanning to distinguish different tissues. At the time of our studies, scaling VO2
to body mass raised to the power of 0.75 (exponent b) occurred as the best available method,
in line with theoretical modeling and empirical studies over a wide range of body masses and 
species (171). Recent investigations published after the present studies, have estimated
different mass exponential values, especially at maximal metabolic rate as indicated by 
VO2max. By re-examining 34 eutherian mammalian species ranging 7 g to 500 kg from a large 
body of published data (31 original reports, including paper II), it was found that VO2max
should be reported in relation to a body mass with the exponent b 0.872 (± 0.029, 95% 
confidence limits 0.813-0.932; 184,185). However, the exponent b may differ between athletic
and non-athletic phenotypes, as a tight connection was found between how VO2max relates to 
body mass and aerobic capacity in the skeletal locomotor muscles. The allometric cascade
was also examined with a different multiple-cause model, in which the relative contributions
along a detailed cascade were assessed, from pulmonary ventilation and alveolar-to-arteriolar
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oxygen diffusion, to skeletal muscle fiber, Ca2+ pump and myosin ATPase activities at the 
receiving end (81). With this approach, the exponent b was found to be 0.84-0.92 during
maximal metabolic rate, and 0.74-0.77 during basal metabolic rate. However, when re-
analyzing our VO2max data with the mass exponent 0.872, the conclusions remained the 
same, since body masses remained similar between trained and sedentary animals.
Following the best current approximation, cardiac weights were related to body mass with the
exponent 0.78 (10). In paper II, skeletal muscle weights were also measured. To the best of 
our knowledge, no previous studies could advice on how to scale appropriately. Therefore, we 
calculated the exponent b from the present population by allometric equations. This approach
yielded the exponent b 0.75, almost similar to the cardiac exponent. However, care should be
granted, as defining a valid exponential power usually requires a much larger pool of data 
(90).
Statistical Analysis
As each study operates with a limited number of animals per group, data were analyzed by 
non-parametric procedures and complemented by one-way and repeated measures ANOVA,
where appropriate. In papers III and IV, we investigated which cellular factors best 
corresponded to VO2max, to identify the cellular determinants of aerobic fitness. Such attempts
were performed by simple univariate and multivariate linear regression analyses. Although 
this approach identified several cellular features, variables that did not reach statistical
significance may still be biologically important. The backward stepwise model was chosen to 
include all independent variables and then remove insignificant ones one at the time until a 
final model with significant cellular contributors was achieved. However, the same variables
were identified using the forward stepwise model. 
23
SUMMARY OF RESULTS
PAPER I Intensity-controlled treadmill running in rats: VO2max and cardiac
  hypertrophy
The objectives of this study were to develop and evaluate experimental procedures for 
determining VO2max during treadmill running in rats of both sexes, and to determine the effects 
of long-term high-intensity treadmill exercise training at 85-90% of VO2max.
Evaluation of Test Procedures
1. Repeated measurements of submaximal running yielded a high reproducibility:
VO2: r = 0.96, coefficient of variation = 4%.
Heart rate: r = 0.98, coefficient of variation = 1.5%. 
2. Optimal treadmill inclination for measuring VO2max: 25° (47%). 
3. Respiratory exchange ratio > 1.05 and blood lactate > 6.0 mM confirmed exercise
level at or close to exhaustion.
4. Linear relationship between VO2 and heart rate was found during increasing treadmill
running velocities; maximal heart rate required higher velocities than VO2max.
5. VO2 leveled off (VO2max) during treadmill running, despite increased running velocity.
Effects of Regular Exercise Training
1. Exercise training induced an athletic phenotype resembling human cardiopulmonary
adaptations to exercise.
2. VO2max and maximal aerobic running velocity increased 60-70%.
3. Resting and maximal oxygen pulse increased 25-30%, indicating increased stroke
 volume. 
4. Exercise training improved running economy during submaximal treadmill velocities:
Oxygen cost decreased ~16%.
Heart rate decreased 11-13%.
Respiratory exchange ratio decreased ~5%
5. Exercise training induced myocardial hypertrophy; right and left ventricular weights
increased 23-34%, while left ventricular myocyte length increased 6-12%.
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PAPER II Intensity-controlled treadmill running in mice: cardiac and skeletal 
  muscle hypertrophy
The objective was to extend the experimental treadmill running protocols into a mouse model.
Thus, the study established valid and reproducible protocols for determining aerobic capacity,
and protocols for exercise-induced cardiopulmonary adaptations in mice of both sexes similar
to those reported in rats and humans.
Evaluation of Test Procedures
1. Repeated measurements of submaximal VO2 yielded a high reproducibility: r = 0.98,
coefficient of variation = 9.1%.
2. Optimal treadmill inclination for measuring VO2max was 15-35°; highest respiratory
exchange ratios were obtained at 25°. 
3. VO2 increased linearly with increasing treadmill velocity, until leveling off at VO2max,
despite increasing running velocity. Respiratory exchange ratio > 1.0 confirmed
exercise level at or close to exhaustion.
Regular Exercise Training
1. Regular exercise training in mice of both sexes induced a similar athletic phenotype
as in paper I, and resembled human cardiopulmonary adaptations to exercise.
2. VO2max increased 30-50%; maximal aerobic running velocity increased ~70%.
3. Exercise training improved running economy during submaximal treadmill velocities:
Oxygen cost decreased 19-25%.
Respiratory exchange ratio decreased ~8%
4. Exercise training induced myocardial hypertrophy; left and right ventricular weights
increased 19-29% and 12-17% in females and males, respectively. Left ventricular
myocyte length and width increased ~20-30% in both sexes.
5. Echocardiography indicated cardiac hypertrophy.
6. Extensor digitorum longus and soleus skeletal muscle weights increased 12-18%
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PAPER III Moderate vs. high exercise intensity: differential effects on aerobic
  fitness, cardiomyocyte contractility, and endothelial function
The objective was to determine how regular exercise at either high (85-90%) or moderate (65-
70%) intensity exercise affects VO2max, cardiomyocyte contractile capacity and arterial
endothelial function.
1. High and moderate intensity exercise increased VO2max 71% and 28%, respectively.
2. High intensity exercise increased cardiomyocyte size 14% by proportional length and 
width growth, whereas moderate intensity increased cardiomyocyte length by 5% and 
cell width indicated growth. Ventricular weights and echocardiography indicated
intensity-dependent biventricular hypertrophy.
3. Cell fractional shortening increased 45% and 23% with high and moderate intensity
exercise, respectively. Intensity-dependent resting bradycardia was indicated.
4. Cardiomyocyte contraction rates increased 43% and 39%, whereas relaxation rates 
increased 20% and 10% with high and moderate intensity exercise, respectively.
Rates of systolic and diastolic Ca2+ transient increase and decay paralleled
contraction and relaxation rates. 
5. Diastolic Ca2+ levels and Ca2+ transient amplitudes were unaffected by exercise
training, whereas Ca2+ sensitivity index increased 40% and 30% after high and 
moderate intensity exercise, respectively.
6. Arterial endothelium-dependent relaxation improved with high and moderate intensity
exercise; acetylcholine concentration evoking half-relaxation decreased 4.3-fold and
2.8-fold with high versus moderate intensity, but the difference between the exercise
intensities was not statistically significant.
7. Differential integrative effects were paralleled by intensity-dependent adaptations on 
cardiomyocyte hypertrophy and myocyte contractile function, but not so clearly with
arterial endothelial function. Multivariate regression analysis showed that rates of
systolic Ca2+ increase and diastolic cell relaxation corresponded best with VO2max,
although also degree of cell hypertrophy and contraction, and vasorelaxation 
correlated to VO2max with univariate analysis.
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PAPER IV Aerobic fitness is associated with cardiomyocyte contractile capacity
and endothelial function in exercise training and detraining
The objective was to determine the time-course of VO2max and associated cellular changes
after regular high intensity exercise was implemented and withdrawn (detraining).
Time-Course of Adaptations to Implementation of Exercise Training (2-13 Weeks)
1. VO2max and cardiomyocyte size, fractional shortening, and rates of myocyte 
relengthening and Ca2+ decay improved steadily up to ~8-10 weeks.
2. Multivariate regression analysis identified cardiomyocyte elongation and diastolic
function as the main factors for determining VO2max, although cell shortening and
volume also correlated with VO2max in univariate analysis.
Time-Course of Adaptations to Detraining (2-4 Weeks)
1. About 50% of the exercise-gained increase in VO2max vanished within 2 weeks of 
detraining, and plateaued 5% above sedentary controls after 3-4 weeks.
2. Cardiomyocyte length and width increased 20-22% with exercise training. During
detraining, cell width regressed completely within 2 weeks, whereas length remained
7% increased after 2 weeks and 5% after 4. 
3. Myocyte fractional shortening increased 30% with exercise, but vanished almost
completely within 2 weeks of detraining. The training-induced increase in contraction-
relaxation rates and corresponding Ca2+ transient rates regressed within 2-4 weeks.
4. Diastolic Ca2+ levels and Ca2+ transient amplitudes were unaffected by exercise
training and detraining, whereas Ca2+ sensitivity index increased with training, and
regressed gradually within 4 weeks of detraining.
5. Endothelial function improved after exercise training, and regressed completely within
2 weeks of detraining.
6. Cardiomyocyte length and endothelial function appeared as the main cellular
determinants for regressed VO2max with detraining (multivariate regression analysis),
whereas univariate analysis also showed that fractional shortening and rates of 
contraction-relaxation and Ca2+ transient correlated significantly with VO2max.
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DISCUSSION
The working hypothesis of the present thesis was that VO2max is associated with cellular
changes in the heart and in arteries. The magnitude of change depends on exercise intensity.
Adaptations occur shortly after initiating regular exercise training, level off after ~2 months, 
and vanish almost completely within a month of detraining. Given that the level of VO2max is 
closely related to clinical outcome, optimizing exercise programs is likely to yield significant
health benefits.
Evaluation of Test Procedures for Oxygen Uptake
The procedures for determining VO2 during treadmill running were found reproducible and
valid both for rats and mice (I and II). To be strict, this validates measurements of submaximal
VO2 and not VO2max. However, hallmarks of appropriate procedures for determining VO2max
are linear relationship between submaximal VO2 and running speed, leveling off of VO2
despite continued increase in running velocity (VO2max), reproducible values from the same
individual when duplicating tests with different inclinations, respiratory exchange ratios >1.0,
linear heart rate response up to maximal levels (I), and clinical signs of exhaustion. These
results are indicative of appropriate experimental procedures for determining VO2max in rats
and mice (I and II). Our methods resemble clinical procedures in healthy and diseased human
individuals (181). Thus, the procedures were valid to determine relative exercise intensity and
evaluate adaptations to regular exercise training. 
Exercise Training Improves Maximal Oxygen Uptake and Cardiac Function
As expected, VO2max and maximal aerobic running velocity increased with regular exercise
training (I-IV). Improvements on VO2max of 50-70% in rats and 30-50% in mice are among the 
largest reported, which probably reflects the close control of relative exercise intensity (for 
comparisons, see Discussion sections in papers I and II). Although several factors influence
aerobic fitness, VO2max is by far the most important (77,145). Nonetheless, regular exercise
also improved work economy considerably, as VO2 and respiratory exchange ratio during
submaximal running decreased. VO2max is closely related to cardiac function (59,194). Thus,
improved cardiac output accounts for a large component of increased VO2max (176,177), as 
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confirmed by increased oxygen pulse (I), which indicates larger stroke volume. Both diastolic
and systolic function and hypertrophy of the heart account for higher cardiac output. Multiple 
regression analysis identified hypertrophy, diastolic function, and Ca2+ handling of the 
cardiomyocyte as important cellular mechanisms of increased VO2max, whereas single
univariate analysis also found that myocyte systolic function correlated well with VO2max (III 
and IV). 
Maximal Oxygen Uptake is Pliable to Different Exercise Intensities
High versus moderate exercise intensity during training sessions doubled VO2max, even 
though moderate intensity induced a substantial increase (III). In fact, moderate exercise
intensity increased VO2max to a degree previously regarded as high (134). Recently, intensity-
dependence of training-induced VO2max has been confirmed in clinical trials of cardiovascular
patients; high intensity exercise was superior for clinical outcome (see Introduction). This has
important consequences since epidemiological data suggest that VO2max is closely linked to 
health and survival (93,136). Surprisingly though, no studies have thoroughly examined the 
effects of different exercise intensities on VO2max in healthy individuals during long-term
exercise programs, although clues of intensity-dependence were provided early on also in 
healthy adults (39).
Time Course of Adaptations in Maximal Oxygen Uptake
Implementing regular high intensity exercise in previously inactive individuals imposes a rapid
augmentation in VO2max up to ~8 weeks, whereupon it leveled off (IV). This probably reflects 
that at one point, exercise training shifts to maintaining fitness, leaving little room for 
improvement unless higher doses of exercise are implemented (195).
The time course of regressed VO2max is considerably shorter in rats than humans, as VO2max
perished almost completely to sedentary levels in less than 1 month (IV). Ten days of 
detraining in well-trained men did not reduce VO2max (34), whereas 8 weeks detraining in 
previously active men and women only modestly decreased VO2max (152). However, the initial 
level of fitness in the latter study was much lower than in paper IV. 
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Cardiomyocyte Hypertrophy with Training
Cardiomyocyte hypertrophy was shortly induced after initiating a regular exercise training
program, and continued steadily for ~2 months, when hypertrophy plateaued (IV). The 
magnitude of cardiomyocyte hypertrophy was dependent upon the intensity of regular
exercise, as high intensity exercise training induced a substantially more pronounced
response than moderate intensity, 14% vs. 5% longer cells, respectively (III). Cell width also 
increased after high intensity exercise (III and IV), but was only indicated with moderate 
intensity (III). Thus, high intensity exercise provides a stronger hypertrophy stimulus than 
moderate intensity. Moreover, proportional cardiomyocyte length and width hypertrophy was
also induced by high intensity exercise in mice.
Physiological hypertrophy is considered beneficial to improve the cardiomyocyte contractile
capacity. It provides a cellular basis for larger end-diastolic dimensions, and confirms with the 
concept of athletes’ heart, i.e. enlarged left and right ventricular masses and volumes, and 
increased wall thicknesses (58,146,150). Global hypertrophy was indicated by increased left 
and right ventricular weights (I-IV), and by echocardiography indices of enlarged left
ventricular posterior wall and septum thickness (II, III). Exercise-induced cardiomyocyte
hypertrophy corresponds to previous studies (8,129,187,188), including previous studies
reporting increased heart weights in both endurance-trained rats (49) and mice (4,92,125). In
fact, the time course of cardiomyocyte hypertrophy (IV) corresponds well to a study finding 
heart weights to plateau after ~10 weeks of regular exercise, following a continuous increase
from initiation of exercise (33). In contrast, there is a lack of well-controlled studies on 
intensity-dependence of cardiac hypertrophy; in fact, most experimental studies do not control
exercise intensity but rely on fixed treadmill speeds, voluntary wheel running, or swim training.
This is probably because controlling exercise intensity accurately in terms of VO2 requires
more sophisticated and time-consuming protocols. Intensity-dependence of hypertrophy may 
explain why only top endurance athletes develop hypertrophied, athletic hearts, whereas less
intense programs usually do not (146,147). Cardiac factors account for the ability to increase
stroke volume linearly with exercise intensity up to near-exhaustion in well-trained endurance
athletes (59,194), and not just up to ~50-60% of VO2max as previously suggested (195). This is
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probably why the magnitude of cardiomyocyte adaptation depends on exercise-intensity
beyond moderate levels.
Hypertrophy Regression with Detraining
Regression of cardiomyocyte hypertrophy with inactivity following a period of regular exercise
(IV) is consistent with previous studies of deconditioning after regular swim training in rats. 
After 9-10 weeks of daily unloaded swimming that increased heart weights similar to the 
present studies (I-IV), 80% of the gained heart weight was lost after 2 weeks of detraining
(56), and 100% after 3 weeks (33). In fact, 60% of training-induced gain in heart weight was
lost one week after stopping regular exercise (79). In the latter study, the training period 
lasted only 3 weeks, rendering the degree of hypertrophy uncertain. Finally, it was shown that
both training- and detraining-induced changes in heart weight are repeatable and susceptible
to successive exercise programs (78). Jointly, our data and the previous reports suggest that 
cardiomyocyte size is closely regulated according to changes in physiological needs.
Regression of cardiomyocyte size is probably the mechanism of myocardial hypertrophy
regression in humans, although time course may be slower. Ten days of detraining did not 
induce any regression in well-trained athletes (34), whereas hypertrophy regression was
evident after 3 weeks of detraining in athletes with similar endurance level (120). Thus, the 
rate of global cardiac regression in humans is probably considerably longer. About ~50% of 
former elite athletes experienced complete regression of left ventricular mass, whereas
almost all maintained enlarged chamber volume during 13 years of follow-up after ceasing
competitive sports (147). Given the participants history of exercise training, it is posible that 
continued leisure activity may have maintained a certain degree of hypertrophy.
Cardiomyocyte Contribution to Myocardial Changes
Cardiac myocytes seem to have an ample potential of adaptation to regular exercise training
and inactivity. Although the present results (I-IV) did not quantify contributions of water and
connective tissue, other studies have. The roles of connective tissue and collagen were 
minimal for regulation of cardiac weights during exercise training and detraining (78,79), 
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whereas myocardial hydration did not contribute at all (33). However, the latter study 
indicated a minor role for non-myocyte protein components to changed heart weights. Thus,
the combined data show that cardiomyocyte size account for the major part of training-
induced cardiac hypertrophy and detraining-induced regression.
Mechanisms of Cardiomyocyte Size Adaptation 
Physiologic hypertrophy has been associated with proportional increase in length and width of
the cardiomyocyte (83), but this has not been demonstrated experimentally until now (II-IV). 
Other studies in our laboratory (I; 187,188) and elsewhere (129) have only reported increased
cell length after regular training. The reason for this discrepancy is presently unclear, but may 
rely on the accuracy of measurements and number of cells studied. Proportional hypertrophy
requires generation of new sarcomeres in series and parallel. Longer cardiomyocytes do not
have longer sarcomeres (129), whereas tissue generation by differentiation, dedifferentiation,
or stem cell proliferation remains dubious, although such traces have been found in infarcted
hearts (12). Regression of cell length and width also occurs proportionally (IV). 
Physiological and pathological hypertrophy is characterized by different molecular phenotypes
and gene expression profiles (85,86). The underlying molecular mechanisms of adding and
removing sarcomeres have not been determined, but several important mechanisms have 
been identified. Physiologic growth appears to rely on initiation of the phosphoinositol-3-
kinase/AKT pathway to stimulate mTOR/p70 S6K signal transduction to increase rate of
protein translation in the ribosomal machinery (19,25,125). Other suggested targets involve 
the Ca2+-binding protein S100A1 (131) and the transcription factors GATA4 and GATA6 
(102). Signal cascades normally associated with pathologic growth, such as atrial and brain 
natriuretic peptides (ANP and BNP; 108) and reprogramming into a fetal gene program (83) 
are usually depressed during physiological hypertrophy, although mildly increased mRNA 
levels of cardiac ANP and BNP also have been reported with mice voluntary running (4).
Hypertrophy regression has been linked to depressed protein synthesis (56). Other
mechanisms could also contribute, e.g. increased rates of protein metabolism or degradation
to reduce redundant sarcomere mass.
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Cardiomyocyte Contractility during Exercise Training and Detraining 
Regular exercise training enhanced cardiomyocyte fractional shortening and rates of systolic
contraction and diastolic relengthening (III and IV). The magnitude of improvement was larger 
with high intensity exercise than with moderate intensity (III). The adaptations increased 
steadily with regular exercise until a plateau was reached after ~2 months, whereas during
detraining, adaptations subsided within 2-4 weeks (IV). No previous accounts exist of time 
course of cardiomyocyte contractile function after exercise training with different intensities or 
during detraining, but magnitude of improvements were in line with most data (e.g. 43,46,129, 
187,188), but not with studies reporting no effect or decreased contractility (98,144,193).
Different exercise training protocols and experimental conditions, e.g. ionic concentrations,
pH, temperature, stimulation frequencies, and region of the heart from which cells were
isolated, may explain some of the variation. Most studies did not stimulate cells up to 
physiological frequencies (7-10 Hz; e.g. 98); where our exercise-induced effects were most
marked (III and IV). Together with hypertrophy, improved contractility effectuates a 
substantially greater contractile capacity of the cell, which contributes to greater systolic
output and diastolic filling. Increased stroke volume is usually associated with resting
bradycardia, as indicated in II and III. 
Electrical versus Current Stimulation of Cardiomyocytes
Field stimulation does not completely resemble ordinary action potential-derived excitation-
contraction coupling and should thus only cautiously be compared to patch-clamped cells 
stimulated with ion currents. For instance, field stimulation changes triggering mechanisms
into dependence on L-type Ca2+ current and reverse mode NCX-current, instead of initiation 
by the Na+ current, with the consequence that time to contraction is prolonged (24). In our 
hands, the extent of cell shortening with field stimulation has continuously been among the 
largest compared to other laboratories, with values regularly between ~15-25% at 7 Hz 
stimulation. Fractional shortening varies reportedly between ~3% and ~25%, in line with 
concordantly large variations in [Ca2+]i amplitudes (15). Such differences probably result from 
experimental conditions, e.g. temperature, pH, concentrations of Ca2+ and other ions,
stimulation frequencies, selection of cells, species and strains, and procedures for isolating
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and culturing cardiomyocytes. These factors may also partially explain the controversy
regarding a positive or negative force-frequency relationship (21,53). In our experimental
conditions and procedures, we typically observed a positive staircase during 1-7 Hz
stimulation, but negative >7 Hz (papers III and IV). This relationship is also maintained in 
heart failure cells (109). Furthermore, our approach studies intrinsic, unloaded contractile
properties of the single cardiomyocyte, as mechanical influences by adjacent cells, tissues
and impending in vivo load, as well as neurohormonal stimulation are removed.
Calcium Handling is Linked to Contraction-Relaxation Rates
The inter-dependency and the similar changes on [Ca2+]i transients and contraction-relaxation
velocities suggests that increase in rate of Ca2+ cycling explains faster shortening and 
relengthening of the trained cardiomyocytes (III and IV). Reduced rates of Ca2+ cycling with
detraining also translate into slower contraction-relaxation rates (IV).
Altered Ca2+ handling and contractile capacity of the cardiomyocyte (III and IV) suggest that 
cellular adaptations contribute to improved global heart function in endurance-trained
subjects, such as increased end-diastolic volume, stroke volume, and cardiac output (59,155,
162,194). Cell shortening has also been linked to myocardial contractility in heart failure 
(109). Regressed Ca2+ handling (IV) probably contributes to the detraining-induced reduction
of stroke volume (32,120). Intensity-dependence of cardiac function has not been shown
previously, but based upon paper III, we hypothesize that high intensity exercise is superior to
moderate intensity to induce cardiac effects. Our results are of unloaded shortening with zero 
external work output, whereas in vivo loaded shortening includes external work due to tissue 
mass and blood pressure. However, single cell force- and power production also increase
with regular exercise (43). Together, these results form a cellular basis for increased
myocardial capability to perform external work, although effects of mechanical stress and 
neurohormonal stimulation are not accounted for (see Methods section for details).
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Mechanisms of Altered Calcium Handling
Molecular changes that mechanistically explain the observed changes in Ca2+ handling or 
excitation-contraction coupling have not been determined, although clues are provided. More 
effective coupling of the L-type Ca2+ current to RyR2 Ca2+ release, but not more channels,
has been shown with regular exercise (128,144). This suggests a mechanism for exercise-
induced higher rate of systolic [Ca2+]i transient increase (III and IV). Training-induced effects 
on isolated SR Ca2+ release per se have not been studied, but could potentially be interesting
as the RyR2 complex is responsive to different stimuli (35,55,113,183). Faster [Ca2+]i
transients decay after exercise training (III and IV) seems to at least partly be explained by 
increased levels of SERCA2a, PLN and NCX (114,187,188). This improves Ca2+ re-
sequestering and myocyte relaxation, and may secondarily improve contraction due to 
improved loading of the SR.
Calcium Sensitivity Accounts for Fractional Shortening
In rats, changed cardiomyocyte fractional shortening with exercise training or detraining could
not be explained by systolic or diastolic levels of [Ca2+]i or transient amplitude (III and IV). This 
suggests that the magnitude of cell shortening results from improved myofilament
responsiveness to Ca2+. Indeed, papers III and IV indicate that Ca2+ sensitivity improves with 
regular exercise training according to exercise intensity, and wanes with detraining.
Adaptation of cardiac Ca2+ sensitivity to exercise training has previously been demonstrated
thoroughly in rats (46) and has therefore been suggested as an important mechanism of 
intensity-dependency and time courses of increase and regression of cell fractional
shortening (III and IV). Length-dependence of sarcomere Ca2+ sensitivity; stretched
sarcomeres producing more force (44), implies that end-diastolic volume also may explain 
why myofilament Ca2+ responsiveness changes. These studies may also support the notion 
that Ca2+ sensitivity may be a compensatory mechanism to volume overload (148). Since the 
variation on Ca2+ sensitivity among different species is considerable (67,69,70,109,148,164)
and no supportive data beyond rats exist (46, 188), the possibility remains that improved Ca2+
sensitivity is species-specific.
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Mechanisms of Calcium Sensitivity
Likely mechanisms of changed Ca2+ sensitivity (III and IV) are found in the contractile
machinery of the cell. The levels of atrial myosin light chain-1 in the heart (45), but also 
isoform shifting of troponin T (7), troponin I (100), and myosin heavy chains (137) have been
associated with altered Ca2+ sensitivity. Regulation of pH may also affect Ca2+ sensitivity 
since protons may compete with Ca2+ and inhibit Ca2+-binding to troponin C (141).
Molecular Coupling Between Hypertrophy and Contractility
Exercise training induces simultaneous adaptations on contractile function and size of the 
single cardiomyocyte (III and IV; see figure 2E paper IV). If the newly generated contractile 
machinery also contributes to improved contractility, then it suggests that intracellular
regulatory mechanisms are activated, such as different protein kinases and phosphatases
(e.g. 135). An interesting hypothesis is that the AKT pathway stimulates hypertrophy and 
facilitates Ca2+ cycling in concert (25). 
Endothelium-Dependent Arterial Relaxation
Regular exercise training induced greater arterial endothelial function, but the effects were not
significantly different between high and moderate exercise intensity (III), and vanished 
completely within days of detraining (less than 2 weeks; IV). Endothelium-mediated
vasorelaxation measures the conductive ability of the artery (vasodilation), although
endothelial function also includes mechanisms that protects against atherosclerosis (see 
Introduction). Exercise may therefore reverse endothelial dysfunction and exert anti-
atherosclerotic effects on the endothelium. Thus, some effects of exercise training may be 
more marked in individuals with endothelial dysfunction.
Intensity-Dependence of Endothelium-Dependent Relaxation
Although endothelium-mediated vasorelaxation was indicated better after high intensity 
exercise training versus moderate, no statistical significance occurred between the exercise 
levels (III). No clear consensus has evolved on endothelial adaptations to exercise training in 
healthy individuals. Despite endothelium-dependent vasodilatation improving with moderate
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intensity exercise (50% of VO2max), it did not improve with high (75%) or low (25%) exercise
intensities (61). Other reports show that endothelial function may improve (29,99,124),
decrease (13) or remain unchanged (95,117,123) during regular exercise training. It was also 
reported that endurance-trained women do not have better endothelial-mediated
vasodilatation than sedentary counterparts, but have structurally greater artery diameters 
(127). These discrepancies may be due to inadequate exercise programs, experimental
procedures, selection of the specific artery to study (e.g. large conduit artery vs. smaller and 
more responsive arteries), initial status of the endothelium (normal vs. unhealthy), and 
inherent differences between human and animal biology.
In individuals with heart failure and cardiovascular disease, endothelial adaptation is 
associated with exercise-induced improvement of cardiovascular health and work capacity
(3,71-73,97,106). This suggests that arterial adaptive potential may be larger when 
endothelial dysfunction is present.
Regression of Improved Endothelium-Dependent Relaxation
Regular exercise carried out for 10 weeks improved endothelial function substantially (III and 
IV). When training was stopped, the effects returned to normal levels within less than 2 weeks
(IV). Given the rapid decline, one may assume that regular exercise is necessary to maintain, 
not just induce, improved endothelial function. The time course of regression appears longer
in humans, as endothelial function returned to baseline ~2 months after ceasing regular
exercise in patients with coronary artery disease and heart failure (117,180). How quickly
regression progress in healthy humans is uncertain; whereas NO levels were maintained after 
4 weeks of detraining, plasma levels of NO regress within 8 weeks (116).
Mechanisms of Endothelial Adaptation
Since dilatory responses to Na+ nitroprusside and reaction to acetylcholine after eNOS
inhibition with L-NAME were unaffected by training or detraining (III and IV), altered 
vasodilatory effects were probably caused by acetylcholine-mediated NO from the 
endothelium (see figure 2, Introduction). Besides increased eNOS enzyme activity (71), 
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regular exercise training also increases protein levels of eNOS if the tyrosine kinase c-Src is
present (40). Also, increased shear stress and transmural pressure induces higher endothelial
reactivity via AKT and vascular endothelial growth factor (VEGF; 1). 
Although endothelial adaptation seemed to have a different time course than cardiomyocytes
(III and IV), univariate correlation analysis established a weak association with VO2max (III), 
whereas multivariate regression indicated that regressed endothelial function is associated
with VO2max (IV). However, further studies are required to investigate adaptations of the 
endothelium to exercise, especially in subjects with endothelial dysfunction. 
Cellular Mechanisms of Maximal Oxygen Uptake 
It takes a certain amount of flexibility and adaptability to respond to exercise training and 
withdrawal thereof. This thesis shows that changes in VO2max during training and detraining
are closely associated with adaptation in cardiac myocytes. It should be noted that statistical 
modeling to assign values to cellular determinants cannot provide causal proofs but indices,
and does not take into account other variables not measured or controlled for. Nonetheless, it 
provides important targets for more defining studies. Although the scope of this thesis was on
oxygen delivery and identifies cardiomyocyte contractile capacity as a main determinant of 
aerobic fitness, other biological factors are also important for integrative function after training 
and detraining, e.g. capillarization, mitochondrial mass, and oxidative and metabolic enzymes
(96,132).
General Considerations and Clinical Implications
The data reported here are obtained in healthy rats and mice with no history of cardiovascular
disease, and provide thus insight into processes occurring under normal physiological
conditions. Thus, it remains uncertain how varying degree of disease would affect the results.
Genetic background may also affect the outcome. Both young and old individuals, as well as 
different sexes may react differently to the interventions. Papers I and II indicate that sex 
differences mainly would appear on the magnitude of adaptations, not the nature. It also adds
credibility to translating results from animal to man, that quantitative rather than qualitative 
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differences seem to separate excitation-contraction coupling between the species (14,15). In 
cases were human samples are available, a large degree of similarity between experimental
and clinical studies seem to appear (e.g. 66-73).
The studies were conducted with the intention to identify mechanisms and form a basis for 
studies of exercise training as a therapeutic approach in heart failure and related conditions.
The first such studies in our laboratory show comparable, beneficial effects of training in heart
failure or in animals at risk of developing cardiovascular disease (187,189), in line with other 
studies reporting beneficial effects of exercise training in heart failure (134). Therefore, we 
studied intensity-dependence with a clinical approach by changing exercise intensity without
changing exercise time. This is not a strict control of the sheer effects of exercise intensity per
se, as volume is not adjusted with moderate intensity exercise, but provides evidence that 
clinical and cellular effects increase if exercise intensity is increased within a given period of 
time “set” for exercise. As described in paper III, if one were to appropriately adjust exercise 
time to match volume between groups, the exercise time would approach critical lengths in 
clinical settings. Further experimental and clinical studies of exercise training as a therapeutic
tool, partly based upon the present data, are currently underway and show potentially large 
effects of increasing exercise intensity in patients, even when amount of work is the same.
Given the importance of VO2max for predicting cardiovascular health and all-cause mortality in 
healthy and cardiovascular patients (93,136), our results should have consequences for 
designing appropriate exercise programs and studies. Nevertheless, we recognize that low-
to-moderate exercise (175), and very intense short-bout sprint training (190-193), may also be 
valuable in both health and disease.
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CONCLUSIONS
1. The experimental procedures for determining VO2max and running economy were valid
and reproducible in both rats and mice during inclined treadmill exercise. Thus, the 
protocols could be used to accurately evaluate adaptations to regular exercise
training, and to determine the relative intensity of treadmill running.
2. Regular intensity-controlled exercise training induces robust integrative and cellular
adaptations in rat and mouse. VO2max and running economy improve. Cardiomyocyte
hypertrophy is induced; and contractile function, Ca2+ handling and Ca2+ sensitivity 
increase. Arterial endothelium-dependent vasoreactivity to acetylcholine improved.
3. Regular exercise at high versus moderate intensity induces about two-fold greater
adaptations on VO2max and cardiomyocyte dimensions, fractional shortening, Ca2+
sensitivity, and velocities of contraction-relaxation and Ca2+ transient cycles. In 
contrast, arterial endothelial function was less dependent upon exercise intensity.
4. After implementing regular high-intensity exercise training, VO2max increases rapidly
until a peak level is reached after ~8 weeks. Cardiomyocyte adaptations including
hypertrophy response, fractional shortening, and rates of contraction-relaxation and
Ca2+ transients follow a similar pattern. When regular training is stopped, regression
occurs about twice as fast; most of the effects vanished completely within 2-4 weeks,
except cell size and VO2max, which remained slightly elevated after 4 weeks of 
detraining. In contrast, training-induced arterial endothelium-dependent relaxation
regressed completely within 2 weeks of detraining.
5. Aerobic fitness and VO2max are closely associated with cellular function and 
adaptations to regular training at high and moderate exercise intensities and 
detraining. Multivariate correlation analysis identified cardiomyocyte hypertrophy, rate 
of Ca2+ increase and decay, myocyte relaxation, and endothelial function as the main
variables linked to VO2max. Thus, cardiac cell and endothelium features are dynamic
and show great plasticity to exercise stimuli.
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Figure 3. Summary of the main effects of exercise training at high or moderate intensity, and during detraining
following regular exercise training.
The results indicate that exercise intensity is important for aerobic fitness and cellular
adaptations that underlie health outcomes, and that cardiomyocyte contractile capacity
emerges as an important determinant of VO2max.
VO2max
VO2max
Cardiomyocyte size 
VO2max
In-Training Training Detraining Sedentary
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Time
Cardiomyocyte contractility 
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ERRATA
Paper IV
Page 2899, Figure 2 legend: references should read 6, 18.
Page 2899, last paragraph, line 4: “Figure 1” should read “Figure 2.”
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